Dana G Jr. Mead
CIK 1222358 · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.71M
Companies
6
Total Filings
45
Lifetime Open-Market Net
$1.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LUNG | Director | 143,790 | $1.25 | $179.7K | $500.0K | 8 | 2026-06-09 |
| MOBI | Director | 7,000 | $10.72 | $75.0K | $105.0K | 1 | 2026-05-11 |
| INSP | Director | 26,213 | $51.97 | $1.36M | $320.0K | 9 | 2026-05-04 |
| Inari Medical, Inc. (NARI) Delisted | Director | 0 | $79.97 | $0 | $0 | 6 | 2025-02-19 |
| Intersect ENT, Inc. (XENT) Delisted | Director | 1,751,828 | $28.24 | $49.47M | $99.9K | 14 | 2022-05-16 |
| TDOC | Director | 10,202 | $9.36 | $95.5K | $106.5K | 7 | 2016-08-10 |
Recent Filings · Page 2 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-02 | LUNG | Grant (A) | +12,620 | $0 | EDGAR |
| 2023-05-19 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +2,412 | $0 | EDGAR |
| 2023-05-01 | INSP | Grant (A) | +669 | $0 | EDGAR |
| 2022-06-03 | LUNG | Grant (A) | +5,600 | $0 | EDGAR |
| 2022-05-27 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +2,420 | $0 | EDGAR |
| 2022-05-16 | Intersect ENT, Inc. (XENT) Delisted | U | −24,129 | -$681.6K | EDGAR |
| 2022-05-10 | INSP | Grant (A) | — | $0 | EDGAR |
| 2021-10-05 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +2,190 | $0 | EDGAR |
| 2021-06-11 | LUNG | Grant (A) | +2,810 | $0 | EDGAR |
| 2021-06-07 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | +3,239 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.